Jan L. Posma

Efficacy and Safety of a Novel Cholesteryl Ester Transfer Protein Inhibitor, JTT-705, in Humans

Greetje J. de Grooth, Jan Albert Kuivenhoven, Anton F. H. Stalenhoef et al. · Circulation · 2002 · 455 citations · Full text

Life Sciences, Pharmacology, Pharmacotherapy +17

Time course of hemodynamic changes and improvement of exercise tolerance after cardioversion of chronic atrial fibrillation unassociated with cardiac valve disease

Isabelle C. Van Gelder, Harry J. Crijns, Paul K. Blanksma et al. · The American Journal of Cardiology · 1993 · 271 citations · Full text

Medicine, Cardiology, Physiology +15

Validation and clinical use of a novel diagnostic device for screening of atrial fibrillation

Robert G Tieleman, Y. Plantinga, D. Rinkes et al. · EP Europace · 2014 · 139 citations · Full text

Medicine, Cardiology, Health Informatics +14

Effects of Alagebrium, an Advanced Glycation Endproduct Breaker, on Exercise Tolerance and Cardiac Function in Patients with Chronic Heart Failure

Jasper W.L. Hartog, Suzan Willemsen, Dirk J. van Veldhuisen et al. · European Journal of Heart Failure · 2011 · 122 citations · Full text

Medicine, Cardiology, Cardiac Rehabilitation +15

Increased dispersion of refractoriness in the absence of QT prolongation in patients with mitral valve prolapse and ventricular arrhythmias.

R. G. Tieleman, Harry J. Crijns, Ans C.P. Wiesfeld et al. · Heart · 1995 · 72 citations · Full text

Medicine, Cardiology, Internal Medicine +15